Boston Scientific Receives U.S. FDA Approval For ImageReady™ MR-Conditional Pacing System

Boston Scientific (NYSE:BSX) has received U.S. Food and Drug Administration (FDA) approval for a suite of products deemed safe for use in a magnetic resonance imaging (MRI) environment.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news